Korean J Blood Transfus.
2015 Dec;26(3):235-248. 10.17945/kjbt.2015.26.3.235.
Emerging Infectious Disease and Safety of Blood Components
- Affiliations
-
- 1Blood Transfusion Research Institute, Korean Red Cross, Wonju, Korea. dj57_2000@redcross.or.kr
- 2Blood Services Headquarters, Korean Red Cross, Wonju, Korea.
- 3Department of Laboratory Medicine, Samsung Medical Center, Seoul, Korea.
- 4Department of Laboratory Medicine, Korea University Medical Center, Seoul, Korea.
- KMID: 2139788
- DOI: http://doi.org/10.17945/kjbt.2015.26.3.235
Abstract
- Recently, the emergency of Middle East Respiratory Syndrome in Korea raised public concern regarding emerging infectious disease (EID) and affected the strategy for blood safety. Although some cases of EID such as West Nile virus in the United States and hepatitis E virus in Japan emerged in a restricted area, the emergence can rapidly affect the situation in other countries in a globalized society with advancements in transportation and international exchange. Because the risk of transfusion-mediated infection may occur by the agent of EID which can be transmitted through blood, the strategy for safety must be considered for agents that were not tested in the stage of blood donor screening. We reviewed the characteristics of transfusion-transmissible EIDs raising concerns worldwide and the strategies which had been adopted.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Pathogen Reduction for Platelets
- Suggestions for Advancing the Control of Emerging Infectious Diseases
- Emerging Infectious Disease due to Micorbial Adaptation: Emergence and Spread of Antimicrobial Resistance
- Post COVID-19 Emerging Infectious Diseases: What is the Next Pandemic Agent?
- Emerging Infectious Diseases in the Republic of Korea
